Thursday, May 09 2024
05:00 PM – 05:15 PM ET - Ballroom 4
203: Anellovectors, a Gene Delivery Platform Based on Commensal Human Anelloviruses, Have the Potential to Evade the Immune System and Deliver DNA Payloads to a Broad Range of Tissues in a Redosable Manner
Chris Wright
Ring Therapeutics
Disclosures: C. Wright: 1; Commercial Interest i.e. Company X; Ring Therapeutics. 1; What was received? i.e. Honorarium; Salary,stocks. 1; For what role? i.e. Speaker; Employee.
Related Abstract